Can we consider discontinuation of hypomethylating agents in patients with myelodysplastic syndrome : a retrospective study from The Korean Society of Hematology AML/MDS Working Party

It is often difficult to continue treatment with hypomethylating agent(HMA) in clinical practice because of problems such as toxicities, poor economics, etc. We compared clinical outcomes of those patients who continued HMA and those who discontinued HMA because of other causes, and evaluated factor...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncotarget
Main Authors: Kim, Da Jung, Lee, Ho Sup, Moon, Joon-Ho, Sohn, Sang Kyun, Kim, Hyeoung Joon, Cheong, June-Won, Jo, Deog-Yeon, Kim, Hawk, Lee, Hyewon, Bang, Soo-Mee, Lee, Won Sik, Park, Yong, Lee, Mark Hong, Lee, Jae Hoon, Bae, Sung Hwa, Kim, Min Kyoung
Format: Artigo
Sprog:Inglês
Udgivet: Impact Journals LLC 2017
Fag:
Clinical Research Paper
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5668053/
https://ncbi.nlm.nih.gov/pubmed/29108320
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.18258
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker